Company news

Century Therapeutics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference

September 25, 2023

Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

August 8, 2023

Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

May 10, 2023

Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit

April 16, 2023

Century Therapeutics Announces Leadership Changes

April 11, 2023

Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates

March 15, 2023

Century Therapeutics to Present at the AACR Annual Meeting 2023

March 14, 2023

Century Therapeutics to Present at Upcoming Investor Conferences

February 20, 2023

Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas

February 7, 2023

Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026

January 4, 2023

Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 3, 2023

Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference

November 21, 2022

Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates

November 10, 2022

Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

November 9, 2022

Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022

November 1, 2022

Century Therapeutics to Present at the SITC 37th Annual Meeting

October 4, 2022

Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors

October 2, 2022

Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference

September 25, 2022

Century Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

September 5, 2022

Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection

August 24, 2022

Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

August 10, 2022

Century Therapeutics Announces Its Addition to the Russell Microcap® Index

June 23, 2022

Century Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium

June 20, 2022

Century Therapeutics to Host Virtual Research and Development Day on June 13, 2022

June 5, 2022

Century Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates

May 15, 2022

Century Therapeutics to Present at the ASGCT 25th Annual Meeting

May 1, 2022

Century Therapeutics to Present at the Chardan Genetic Medicines and Cell Therapy Manufacturing Summit

April 17, 2022

Century Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

April 5, 2022

Century Therapeutics to Present at the H.C. Wainwright Gene Therapy and Gene Editing Conference

March 22, 2022

Century Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Updates

March 16, 2022

Century Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

February 8, 2022

Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies

January 9, 2022

Century Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 3, 2022

Century Therapeutics Added to the NASDAQ Biotechnology Index

December 16, 2021

Century Therapeutics Announces Presentation of Data at the 63rd American Society of Hematology Annual Meeting and Provides Pipeline Updates

December 15, 2021

Century Therapeutics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 21, 2021

Century Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates

November 9, 2021

Century Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Host Virtual Research & Development Update

November 3, 2021

Century Therapeutics and Outpace Bio Enter Research Collaboration in CAR Engineering

October 6, 2021

Century Therapeutics Announces Its Addition to the Russell 2000® Index

September 16, 2021

Century Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates

August 11, 2021

Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

June 21, 2021

Century Therapeutics Announces Pricing of Initial Public Offering

June 16, 2021

← Newer news releases

Decks

The 5 newest of 35 decks. Every deck is listed under its year.